Gnosis by Lesaffre’s Vitamin K2 Scientific Advisory Committee (K2SAC) held its third meeting on Oct. 31, at Maastricht University’s Cardiovascular Research Institute. The meeting focused on advances in research and how to communicate the findings to the public and brand marketers.
 
“Under my guidance, several young researchers have embraced vitamin K2 as an exciting and novel field of study,” said Leon Schurgers, a researcher and longstanding collaborator with Gnosis by Lesaffre. “Our meeting offered these emerging scientists a platform to explore cutting-edge topics, including the role of K2 in aging and its potential benefits for cognitive health, beyond its already recognized bone and cardiovascular advantages.”
 
Rudolf Bittner, a PhD student, was among those sponsored by a research fund made available by Gnosis by Lesaffre. He presented his findings, “Investigating the Role of Vitamin K2 in Aging: Insights into Mitochondrial Function and Dynamics.” “I’m delighted to share my unpublished research with this esteemed group of experts, fostering insightful discussions,” said Bittner.
 
The event also featured debates, and updates on K2’s applications for kidney health and migraine relief. According to Schurgers, the meeting provided an opportunity to share unpublished clinical research data and explore emerging trends in vitamin K2 applications.
 
The committee also discussed marketing vitamin K2 and addressing the need for clearer understanding of its safety and potential contraindications.
 
“Although Gnosis was excited about publishing a practitioner-focused article about correcting vitamin K2 confusion and misinformation, more effort is needed to educate the public about the importance of safety of this nutrient,” said Hogne Vik, MD, PhD, MBA, member of K2SAC and manager of the Gnosis Substantiation Team. “We are proud to be at the forefront of vitamin K2 research, both basic and clinical, while actively supporting young researchers. Moreover, our involvement in collaborative, non-competitive initiatives, such as ILSI Europe’s new task force on vitamin K2, reflects our commitment to advancing health understanding and economic insights.”